[PHARMA] QoQ Quarter Result on 30-Sep-2022 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
24-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- 1093.49%
YoY- -82.71%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 848,734 880,454 862,720 924,681 761,102 962,174 711,718 12.49%
PBT 6,342 9,193 -638,395 15,589 4,521 37,439 125,088 -86.37%
Tax -4,018 -6,427 -5,802 -6,212 -3,607 -8,583 -39,923 -78.45%
NP 2,324 2,766 -644,197 9,377 914 28,856 85,165 -90.99%
-
NP to SH 1,961 2,648 -644,390 8,617 722 27,734 85,475 -91.98%
-
Tax Rate 63.36% 69.91% - 39.85% 79.78% 22.93% 31.92% -
Total Cost 846,410 877,688 1,506,917 915,304 760,188 933,318 626,553 22.27%
-
Net Worth -137,571 -142,812 -248,894 411,327 406,087 413,947 450,411 -
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div - - - 7,859 6,549 10,479 65,466 -
Div Payout % - - - 91.21% 907.17% 37.79% 76.59% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth -137,571 -142,812 -248,894 411,327 406,087 413,947 450,411 -
NOSH 1,310,208 1,310,208 1,309,126 1,309,126 1,309,126 1,309,126 1,309,336 0.04%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.27% 0.31% -74.67% 1.01% 0.12% 3.00% 11.97% -
ROE 0.00% 0.00% 0.00% 2.09% 0.18% 6.70% 18.98% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 64.78 67.20 65.86 70.59 58.10 73.45 54.36 12.43%
EPS 0.15 0.20 -49.19 0.66 0.06 2.12 6.53 -91.97%
DPS 0.00 0.00 0.00 0.60 0.50 0.80 5.00 -
NAPS -0.105 -0.109 -0.19 0.314 0.31 0.316 0.344 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 58.89 61.09 59.86 64.16 52.81 66.76 49.38 12.49%
EPS 0.14 0.18 -44.71 0.60 0.05 1.92 5.93 -91.82%
DPS 0.00 0.00 0.00 0.55 0.45 0.73 4.54 -
NAPS -0.0955 -0.0991 -0.1727 0.2854 0.2818 0.2872 0.3125 -
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 0.37 0.285 0.545 0.515 0.595 0.755 0.74 -
P/RPS 0.57 0.42 0.83 0.73 1.02 1.03 1.36 -44.08%
P/EPS 247.21 141.02 -1.11 78.29 1,079.54 35.66 11.34 684.78%
EY 0.40 0.71 -90.26 1.28 0.09 2.80 8.82 -87.35%
DY 0.00 0.00 0.00 1.17 0.84 1.06 6.76 -
P/NAPS 0.00 0.00 0.00 1.64 1.92 2.39 2.15 -
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 11/08/23 18/05/23 27/02/23 24/11/22 19/08/22 20/05/22 17/02/22 -
Price 0.42 0.38 0.44 0.55 0.595 0.72 0.76 -
P/RPS 0.65 0.57 0.67 0.78 1.02 0.98 1.40 -40.12%
P/EPS 280.62 188.02 -0.89 83.61 1,079.54 34.01 11.64 739.41%
EY 0.36 0.53 -111.80 1.20 0.09 2.94 8.59 -88.00%
DY 0.00 0.00 0.00 1.09 0.84 1.11 6.58 -
P/NAPS 0.00 0.00 0.00 1.75 1.92 2.28 2.21 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment